Merck

Science-driven cancer medicines

Darmstadt, Germany

Merck refers to two distinct global entities: Merck Group (Germany), a science and technology company in Healthcare, Life Sciences, and Electronics, and Merck & Co., Inc. (USA), a pharmaceutical company focused on cancer treatments, vaccines, and animal health products. Both are prominent in their respective sectors.

Shareable draft

Check out Merck on @MedStartr Today Merck refers to two distinct global entities: Merck Group (Germany), a science and technology company in Healthcare, Life Sciences, and Electronics, and Merck & Co., Inc. (USA), a pharmaceutical company focused on cancer treatments, vaccines, and animal health products. Both are prominent in their respective sectors. #Neurology #Immunology #NeurologyImmunology #MetabolismEndocrinology #Fertility #InfectiousDiseasesAndVaccines #MentalBehavioralHealth #InflammatoryBowelDisease #CardiovascularDisease #CancerOncology #DrugDiscoveryDevelopment #MedMo #MedStartrVentures

https://www.medstartr.ai/s/x1XMOWdjkjU

Get Involved in Merck

How We Help

Core Technology

Developing medicines; providing laboratory reagents, chemicals, and equipment for biotech and pharma; and offering materials and solutions for advanced technologies, including semiconductors, display solutions, and surface solutions, with a focus on innovation and digitalization.

Key Differentiators

Diversified Business Model, Innovation and Technology Leadership (including Materials Intelligence™), Scale and Global Presence, Strategic Acquisitions and Partnerships, Customer Experience and Operational Excellence, Deeply Embedded Sustainability, Long History and Strong Brand Equity

Clinical Focus

Oncology, Neurology & Immunology, Cardiovascular, Metabolism & Endocrinology (CM&E), Fertility, Infectious Diseases and Vaccines

Target Customers

Biotech and pharmaceutical companies, research institutions, electronics manufacturers, hospitals, and clinics.

Product Stage

Mature

Company Info

Business Model: B2B
Founded: 1668
Website: www.merckgroup.com

Disease Areas

Neurology Immunology Neurology & Immunology Metabolism & Endocrinology Fertility Infectious Diseases and Vaccines Mental Health IBD Cardiovascular Disease Cancer & Oncology

Technologies

Medicines DevelopmentLaboratory ReagentsChemicalsBiotech EquipmentPharma EquipmentSemiconductor MaterialsDisplay SolutionsSurface SolutionsDigitalizationInnovationMaterials Intelligence

Clinical & IP

🔬

Clinical Validation

FDA approved subcutaneous KEYTRUDA. FDA accepted RSV prevention BLA (clesrovimab). FDA accepted HIV NDA (doravirine/islatravir). Priority review granted for head/neck cancer. MK-2214 Fast Track Designation (Alzheimers).

🌐Website

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of Merck?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.